CME GROUP INC. vs The Goldman Sachs Group, Inc., two Financial Services stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where CME and GS diverge most: on debt / equity, CME reads 0.00 and GS reads 0.09; on ev/ebitda, CME reads 20.9 and GS reads 60.7. The rest of the comparable metrics sit closer together. What GS's price implies is a somewhat stretched bet versus history (earnings-power basis). The bull and bear cases for each are in their full reports below.
| Metric | CME | GS |
|---|---|---|
| Price | $267.83 | $1017.60 |
| Market cap | $96.8B | $300.2B |
| Sector | Financial Services | Financial Services |
| Stage | Mature | Mature |
| Implied growth (priced in) | +10.3% | — |
| P/E | 22.7 | 18.6 |
| P/B | 3.65 | 2.44 |
| P/S | 14.29 | 4.97 |
| EV/EBITDA | 20.9 | 60.7 |
| Revenue growth | +5.1% | +11.4% |
| Operating margin | 64.9% | — |
| Net margin | 63.3% | 29.9% |
| Return on equity | 16.2% | 14.7% |
| Return on assets | 2.2% | 0.9% |
| Dividend yield | 1.9% | 1.4% |
| Debt / equity | 0.00 | 0.09 |
| Current ratio | 1.02 | — |
| Altman Z (solvency) | 0.46 | 0.24 |
| Piotroski F (quality) | 6 / 9 | 7 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.